GB0523658D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0523658D0
GB0523658D0 GB0523658A GB0523658A GB0523658D0 GB 0523658 D0 GB0523658 D0 GB 0523658D0 GB 0523658 A GB0523658 A GB 0523658A GB 0523658 A GB0523658 A GB 0523658A GB 0523658 D0 GB0523658 D0 GB 0523658D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0523658A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35580407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0523658(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0523658A priority Critical patent/GB0523658D0/en
Publication of GB0523658D0 publication Critical patent/GB0523658D0/en
Priority to NZ604127A priority patent/NZ604127A/en
Priority to RU2008124827/15A priority patent/RU2487711C2/en
Priority to CN200680051365.0A priority patent/CN101360496B/en
Priority to NO20170956A priority patent/NO346575B1/en
Priority to DK10175197.2T priority patent/DK2275103T3/en
Priority to US12/094,173 priority patent/US9006224B2/en
Priority to BRPI0618808-7A priority patent/BRPI0618808A2/en
Priority to PT101751972T priority patent/PT2275103E/en
Priority to ES10175197.2T priority patent/ES2481671T3/en
Priority to PL10175197T priority patent/PL2275103T3/en
Priority to EP10175197.2A priority patent/EP2275103B1/en
Priority to EP06819607A priority patent/EP1954269A2/en
Priority to NZ622710A priority patent/NZ622710A/en
Priority to SI200631791T priority patent/SI2275103T1/en
Priority to NZ568182A priority patent/NZ568182A/en
Priority to CA2629245A priority patent/CA2629245C/en
Priority to AU2006314444A priority patent/AU2006314444C1/en
Priority to KR1020147001555A priority patent/KR20140012218A/en
Priority to CA2933875A priority patent/CA2933875C/en
Priority to JP2008540626A priority patent/JP2009516671A/en
Priority to PCT/EP2006/068656 priority patent/WO2007057457A2/en
Priority to KR1020087014937A priority patent/KR20080071600A/en
Priority to EP08162295A priority patent/EP2022498A3/en
Priority to NO20220050A priority patent/NO20220050A1/en
Priority to CN2013103848215A priority patent/CN103446138A/en
Priority to ZA200804027A priority patent/ZA200804027B/en
Priority to IL191475A priority patent/IL191475A/en
Priority to MA30950A priority patent/MA29966B1/en
Priority to NO20082683A priority patent/NO344288B1/en
Priority to HK11104451.1A priority patent/HK1150746A1/en
Priority to AU2010202866A priority patent/AU2010202866A1/en
Priority to JP2013077748A priority patent/JP5833048B2/en
Priority to CY20141100454T priority patent/CY1115299T1/en
Priority to HRP20140708TT priority patent/HRP20140708T1/en
Priority to JP2014245402A priority patent/JP5963836B2/en
Priority to US14/608,644 priority patent/US20150148294A1/en
Priority to NO20161045A priority patent/NO341023B1/en
Priority to US15/405,501 priority patent/US20170128425A1/en
Priority to IL250697A priority patent/IL250697A0/en
Priority to IL253698A priority patent/IL253698A0/en
Ceased legal-status Critical Current

Links

GB0523658A 2005-11-21 2005-11-21 Organic compounds Ceased GB0523658D0 (en)

Priority Applications (41)

Application Number Priority Date Filing Date Title
GB0523658A GB0523658D0 (en) 2005-11-21 2005-11-21 Organic compounds
NO20220050A NO20220050A1 (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment
CN2013103848215A CN103446138A (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mtor inhibitors
CA2933875A CA2933875C (en) 2005-11-21 2006-11-20 40-o-(2-hydroxyethyl)-rapamycin for use as a sole drug substance in the treatment of carcinoid tumors arising from the foregut, midgut, or hindgut
KR1020087014937A KR20080071600A (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mtor inhibitors
CN200680051365.0A CN101360496B (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mTOR inhibitors
PCT/EP2006/068656 WO2007057457A2 (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mtor inhibitors
DK10175197.2T DK2275103T3 (en) 2005-11-21 2006-11-20 mTor inhibitors in the treatment of endocrine tumors
EP08162295A EP2022498A3 (en) 2005-11-21 2006-11-20 Neuroendocrine tumour treatment
BRPI0618808-7A BRPI0618808A2 (en) 2005-11-21 2006-11-20 use of an mtor inhibitor
RU2008124827/15A RU2487711C2 (en) 2005-11-21 2006-11-20 Treating neuroendocrine tumours
ES10175197.2T ES2481671T3 (en) 2005-11-21 2006-11-20 MTOR inhibitors in the treatment of endocrine tumors
PL10175197T PL2275103T3 (en) 2005-11-21 2006-11-20 mTOR inhibitors in the treatment of endocrine tumors
EP10175197.2A EP2275103B1 (en) 2005-11-21 2006-11-20 mTOR inhibitors in the treatment of endocrine tumors
EP06819607A EP1954269A2 (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mtor inhibitors
NZ622710A NZ622710A (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mtor inhibitors
SI200631791T SI2275103T1 (en) 2005-11-21 2006-11-20 mTOR inhibitors in the treatment of endocrine tumors
NZ568182A NZ568182A (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using MTOR inhibitors
CA2629245A CA2629245C (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment
AU2006314444A AU2006314444C1 (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mTOR inhibitors
KR1020147001555A KR20140012218A (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mtor inhibitors
NZ604127A NZ604127A (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mtor inhibitors
JP2008540626A JP2009516671A (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment using mTOR inhibitors
NO20170956A NO346575B1 (en) 2005-11-21 2006-11-20 Use of 40-O-(2-hydroxyethyl)-rapamycin in the treatment of carcinoid or small cell cancer
PT101751972T PT2275103E (en) 2005-11-21 2006-11-20 Mtor inhibitors in the treatment of endocrine tumors
US12/094,173 US9006224B2 (en) 2005-11-21 2006-11-20 Neuroendocrine tumor treatment
ZA200804027A ZA200804027B (en) 2005-11-21 2008-05-12 Neuroendocrine tumor treatment using m TOR inhibitors
IL191475A IL191475A (en) 2005-11-21 2008-05-15 Use of 40-o-(2-hydroxyethyl)-rapamycin for the manufacture of a medicament for the treatment of pancreatic neuroendocrine tumors
MA30950A MA29966B1 (en) 2005-11-21 2008-05-20 TREATMENT OF NEUROENDOCRINE TUMORS
NO20082683A NO344288B1 (en) 2005-11-21 2008-06-16 Use of 40-O- (2-hydroxyethyl) -rapamycin in pancreatic neuroendocrine tumor therapy
HK11104451.1A HK1150746A1 (en) 2005-11-21 2008-09-23 Mtor inhibitors in the treatment of endocrine tumors mtor
AU2010202866A AU2010202866A1 (en) 2005-11-21 2010-07-07 Neuroendocrine tumor treatment using mTOR inhibitors
JP2013077748A JP5833048B2 (en) 2005-11-21 2013-04-03 Neuroendocrine tumor treatment using mTOR inhibitors
CY20141100454T CY1115299T1 (en) 2005-11-21 2014-06-20 MTOR SUSPENSIONS IN ENDOCRINE TREATMENT TREATMENT
HRP20140708TT HRP20140708T1 (en) 2005-11-21 2014-07-22 mTOR INHIBITORS IN THE TREATMENT OF ENDOCRINE TUMORS
JP2014245402A JP5963836B2 (en) 2005-11-21 2014-12-03 Neuroendocrine tumor treatment using mTOR inhibitors
US14/608,644 US20150148294A1 (en) 2005-11-21 2015-01-29 Neuroendocrine Tumor Treatment
NO20161045A NO341023B1 (en) 2005-11-21 2016-06-22 Use of 40-O- (2-hydroxyethyl) -rapamycin in carcinoid tumor treatment
US15/405,501 US20170128425A1 (en) 2005-11-21 2017-01-13 Neuroendocrine Tumor Treatment
IL250697A IL250697A0 (en) 2005-11-21 2017-02-21 Neuroendocrine tumor treatment using mtor inhibitors
IL253698A IL253698A0 (en) 2005-11-21 2017-07-27 Neuroendocrine tumor treatment using mtor inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0523658A GB0523658D0 (en) 2005-11-21 2005-11-21 Organic compounds

Publications (1)

Publication Number Publication Date
GB0523658D0 true GB0523658D0 (en) 2005-12-28

Family

ID=35580407

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0523658A Ceased GB0523658D0 (en) 2005-11-21 2005-11-21 Organic compounds

Country Status (3)

Country Link
CN (1) CN101360496B (en)
GB (1) GB0523658D0 (en)
ZA (1) ZA200804027B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110755438A (en) * 2019-11-22 2020-02-07 昆明医科大学 Application of levofloxacin antibiotic in preparing anti-cancer drug sensitizing drug and anti-cancer drug thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157898A0 (en) * 2001-04-06 2004-03-28 Wyeth Corp Antineoplastic combinations such as rapamycin together with gemcitabine or fluorouracil
SG153647A1 (en) * 2001-06-01 2009-07-29 Wyeth Corp Antineoplastic combinations
MXPA06009547A (en) * 2004-02-23 2007-01-26 Dana Farber Cancer Inst Inc Method of treating abnormal cell growth using c-met and-tor inhibitors.

Also Published As

Publication number Publication date
CN101360496A (en) 2009-02-04
CN101360496B (en) 2015-02-25
ZA200804027B (en) 2009-03-25

Similar Documents

Publication Publication Date Title
GB0510390D0 (en) Organic compounds
EP1888534A4 (en) Organic compounds
GB0507575D0 (en) Organic compounds
GB0500435D0 (en) Organic compounds
GB0500785D0 (en) Organic compounds
GB0508319D0 (en) Organic compounds
GB0505219D0 (en) Organic compounds
GB0507696D0 (en) Organic compounds
GB0507577D0 (en) Organic compounds
GB0504850D0 (en) Organic compounds
GB0504194D0 (en) Organic compounds
GB0504544D0 (en) Organic compounds
GB0510810D0 (en) Organic compounds
GB0508992D0 (en) Organic compounds
GB0511060D0 (en) Organic compounds
GB0501237D0 (en) Organic compounds
GB0500784D0 (en) Organic compounds
GB0504203D0 (en) Organic compounds
GB0511063D0 (en) Organic compounds
GB0500683D0 (en) Organic compounds
GB0507695D0 (en) Organic compounds
GB0505541D0 (en) Organic compounds
GB0510585D0 (en) Organic compounds
GB0500020D0 (en) Organic compounds
GB0500682D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)